Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Remote monitoring for patients with pacemakers

Official title: Evaluation of Clinical and Economic Benefit Using Remote Monitoring in Patients With Pacemaker (REMOTE-PM)

Run by Yonsei University · NCT06043570 · Data updated 2026-11-12

This study is testing if remote monitoring for patients with pacemakers is as safe and effective as regular in-person check-ups.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment900 (estimated)
SponsorYonsei University
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedJanuary 17, 2023
Main results expectedOctober 2025
Study endsDecember 2027
Registry record updatedSeptember 21, 2023
Trial IDNCT06043570 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-80 who have received a permanent pacemaker with remote monitoring capabilities.

Probably not a fit

Patients with severe organ dysfunction, certain heart diseases, or those who refuse to use the remote monitoring system may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the safety and effectiveness of remote monitoring (RM) technology for patients with implanted pacemakers compared to traditional in-person follow-ups. The study will enroll 900 patients in Korea, who will be randomly assigned to either the RM group or the standard care group. The primary objective is to determine if the rate of major adverse events is similar between the two groups, while secondary objectives will assess the economic benefits of RM and develop guidelines tailored to the Korean context. The trial will also explore the feasibility of implementing a reimbursement policy for remote monitoring services.

Why it matters

Potential benefit: If successful, this study could enhance patient care by providing a safer and more efficient follow-up method for pacemaker recipients.

How similar studies have gone: Previous studies have indicated that remote monitoring can be a safe alternative to traditional follow-up methods, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 18-80 years

  * Patients with permanent pacemaker with SenseAbility feature \& RM

    * Ability to provide informed consent and to complete the study and required follow-up ④ Those who refuse to use remote monitoring system or who live in an environment where remote monitoring system cannot be utilized.

      * Patient who refuse to use or expected to use less than 75% of remote monitoring system.

Exclusion Criteria:

* Severe hepatic and renal insufficiency (AST or ALT ≥ three times of normal upper limit; SCr \> 3.5 mg/dl or Ccr \< 30ml/min)

  * Thyroid gland dysfunction

    * Pregnancy ④ Malignant tumor

      * Severe organic heart disease (such as moderate to severe mitral regurgitation, dilated cardiomyopathy, hypertrophic cardiomyopathy, severe heart valve disease)

        * Life expectancy \< 12 months ⑦ Patients unable or unwilling to cooperate in the study procedures.

Where it's running

  • Severance Cardiovascular Hospital Yonsei University
    Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.